JP2022505388A - 5-ht4受容体アゴニストの新しい使用 - Google Patents
5-ht4受容体アゴニストの新しい使用 Download PDFInfo
- Publication number
- JP2022505388A JP2022505388A JP2021521392A JP2021521392A JP2022505388A JP 2022505388 A JP2022505388 A JP 2022505388A JP 2021521392 A JP2021521392 A JP 2021521392A JP 2021521392 A JP2021521392 A JP 2021521392A JP 2022505388 A JP2022505388 A JP 2022505388A
- Authority
- JP
- Japan
- Prior art keywords
- disease
- dementia
- alzheimer
- parkinson
- methoxypropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023032962A JP2023060148A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
JP2023032963A JP2023060149A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
JP2023032961A JP2023060147A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201841039516 | 2018-10-18 | ||
IN201841039516 | 2018-10-18 | ||
PCT/IB2019/058853 WO2020079630A1 (en) | 2018-10-18 | 2019-10-17 | New uses of a 5-ht4 receptor agonist |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023032961A Division JP2023060147A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
JP2023032962A Division JP2023060148A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
JP2023032963A Division JP2023060149A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2022505388A true JP2022505388A (ja) | 2022-01-14 |
Family
ID=68470571
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021521392A Pending JP2022505388A (ja) | 2018-10-18 | 2019-10-17 | 5-ht4受容体アゴニストの新しい使用 |
JP2023032963A Pending JP2023060149A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
JP2023032961A Pending JP2023060147A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
JP2023032962A Pending JP2023060148A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023032963A Pending JP2023060149A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
JP2023032961A Pending JP2023060147A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
JP2023032962A Pending JP2023060148A (ja) | 2018-10-18 | 2023-03-03 | 5-ht4受容体アゴニストの新しい使用 |
Country Status (15)
Country | Link |
---|---|
US (3) | US20210386727A1 (ko) |
EP (1) | EP3866800A1 (ko) |
JP (4) | JP2022505388A (ko) |
KR (2) | KR20230155613A (ko) |
CN (1) | CN113164465A (ko) |
AU (2) | AU2019361359B2 (ko) |
BR (1) | BR112021007365A2 (ko) |
CA (1) | CA3116650C (ko) |
EA (1) | EA202191044A1 (ko) |
IL (1) | IL282364A (ko) |
MA (1) | MA53918A (ko) |
MX (1) | MX2021004473A (ko) |
NZ (1) | NZ775671A (ko) |
WO (1) | WO2020079630A1 (ko) |
ZA (1) | ZA202102512B (ko) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014509320A (ja) * | 2011-09-19 | 2014-04-17 | スヴェン・ライフ・サイエンシズ・リミテッド | 5−ht4受容体リガンドとしてのヘテロアリール化合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014404001B2 (en) | 2014-08-16 | 2017-12-14 | Suven Life Sciences Limited | Process for large scale production of 1-isopropyl-3-{5- [1-(3-methoxypropyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}- 1h-indazole oxalate |
-
2019
- 2019-10-17 CA CA3116650A patent/CA3116650C/en active Active
- 2019-10-17 CN CN201980079445.4A patent/CN113164465A/zh active Pending
- 2019-10-17 KR KR1020237037657A patent/KR20230155613A/ko not_active IP Right Cessation
- 2019-10-17 WO PCT/IB2019/058853 patent/WO2020079630A1/en active Application Filing
- 2019-10-17 US US17/285,815 patent/US20210386727A1/en active Pending
- 2019-10-17 KR KR1020217014778A patent/KR20210076106A/ko not_active Application Discontinuation
- 2019-10-17 BR BR112021007365-5A patent/BR112021007365A2/pt unknown
- 2019-10-17 NZ NZ775671A patent/NZ775671A/en unknown
- 2019-10-17 MA MA053918A patent/MA53918A/fr unknown
- 2019-10-17 EP EP19798726.6A patent/EP3866800A1/en active Pending
- 2019-10-17 EA EA202191044A patent/EA202191044A1/ru unknown
- 2019-10-17 MX MX2021004473A patent/MX2021004473A/es unknown
- 2019-10-17 AU AU2019361359A patent/AU2019361359B2/en active Active
- 2019-10-17 JP JP2021521392A patent/JP2022505388A/ja active Pending
-
2021
- 2021-04-16 ZA ZA2021/02512A patent/ZA202102512B/en unknown
- 2021-04-18 IL IL282364A patent/IL282364A/en unknown
-
2023
- 2023-03-03 JP JP2023032963A patent/JP2023060149A/ja active Pending
- 2023-03-03 JP JP2023032961A patent/JP2023060147A/ja active Pending
- 2023-03-03 JP JP2023032962A patent/JP2023060148A/ja active Pending
- 2023-03-29 AU AU2023201908A patent/AU2023201908A1/en active Pending
-
2024
- 2024-04-24 US US18/645,140 patent/US20240277690A1/en active Pending
- 2024-04-24 US US18/645,116 patent/US20240293389A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014509320A (ja) * | 2011-09-19 | 2014-04-17 | スヴェン・ライフ・サイエンシズ・リミテッド | 5−ht4受容体リガンドとしてのヘテロアリール化合物 |
Also Published As
Publication number | Publication date |
---|---|
KR20230155613A (ko) | 2023-11-10 |
CA3116650A1 (en) | 2020-04-23 |
US20240277690A1 (en) | 2024-08-22 |
EP3866800A1 (en) | 2021-08-25 |
ZA202102512B (en) | 2024-06-26 |
JP2023060149A (ja) | 2023-04-27 |
US20240293389A1 (en) | 2024-09-05 |
CN113164465A (zh) | 2021-07-23 |
AU2019361359A1 (en) | 2021-05-20 |
IL282364A (en) | 2021-06-30 |
US20210386727A1 (en) | 2021-12-16 |
JP2023060148A (ja) | 2023-04-27 |
AU2023201908A1 (en) | 2023-05-04 |
CA3116650C (en) | 2023-08-22 |
JP2023060147A (ja) | 2023-04-27 |
AU2019361359B2 (en) | 2023-04-20 |
EA202191044A1 (ru) | 2021-07-13 |
BR112021007365A2 (pt) | 2021-07-20 |
MX2021004473A (es) | 2021-08-24 |
NZ775671A (en) | 2024-07-26 |
KR20210076106A (ko) | 2021-06-23 |
WO2020079630A1 (en) | 2020-04-23 |
MA53918A (fr) | 2022-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20150322049A1 (en) | Leukotriene pathway antagonists for the treatment of dementia, cognitive deficits in parkinson's disease and/or learning and memory deficiencies in parkinson's disease | |
JP6959371B2 (ja) | 純粋な5−ht6受容体アンタゴニストの新たな使用 | |
JP6606298B2 (ja) | 純粋な5−ht6受容体アンタゴニストのnmda受容体アンタゴニストとの組合せ | |
JP6629464B2 (ja) | 純粋な5−ht6受容体アンタゴニスト、アセチルコリンエステラーゼ阻害剤及びnmda受容体アンタゴニストの3種類の組合せ | |
JP2022505388A (ja) | 5-ht4受容体アゴニストの新しい使用 | |
EA047954B1 (ru) | Новые применения 5-ht4 рецепторного агониста | |
EA045076B1 (ru) | Новые применения 5-ht4 рецепторного агониста | |
CN114761008B (zh) | 用于在患有痴呆的患者中治疗行为和心理症状的方法 | |
JP2024156953A (ja) | 認知症患者における行動・心理症状を治療するための方法 | |
EA047219B1 (ru) | Способы лечения поведенческих и психологических симптомов у пациентов с деменцией |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210607 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220704 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221004 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221205 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230626 |